In essence, patient-centered outcomes research sees how the research about diseases, disorders and health conditions-as related to prevention, diagnosis, treatment and management-stacks up and provides those findings for consideration. The comparisons will take into account the health outcomes of the studies, clinical effectiveness, appropriateness of medical treatments and services. Run by a 19-member board, members will only review and consider research that has been through the peer-review process, similar to NIH's process.
The board will include a representative from the National Institutes of Health and the Agency on Healthcare Research and Quality –most likely the person in the position of director, unless the director of these respective agencies has appointed someone else to the board to take their place. Members appointed to the board by the comptroller of the United States will serve six-year terms.
The Institute will also create and carry out a national comparative effectiveness research agenda, complete with specific research priorities and funding to contract with federal agencies, academic institutions and private research groups that will conduct comparative effectiveness research studies. Research will not be allowed to take into account cost-effectiveness. To help set the research agenda, the board will be counseled by internal advisory boards. All findings will be released to the general public within 90 days.
Center for Medical Technology Policy
Comparative Effectiveness Research
Current PCORI Members
PCORI Meetings and Events
You will need Adobe Acrobat® Reader™ to view PDF files located on this site. If you do not already have Adobe Acrobat® Reader™, you can download here for free.